Bee Pharma Africa and a Flying Pharmacy
September 28, 2016
From: FoodTank
Bee Pharma Africa hopes to build a coalition for research in the use of bee propolis and other bee products for treating human diseases.
by Rocco Pallin
Hugo Fearnley of Whitby, England is studying the potential of bee-produced medicines for the treatment of human diseases. Fearnley, CEO of BeeVital and Director of the Apiceutical Research Centre (ARC), recently earned a Churchill Travelling Fellowship to fund his research and coalition-building in four African countries.
One potentially promising compound for Fearnley is propolis, sometimes called bee glue: a mixture of plant resins and wax used for structural purposes in hives. Researchers are studying the roles of propolis in insect disease resistance and the evolutionary benefits of propolis for bees. But Fearnley aims his studies on propolis for treatment of malaria, leishmania, and sleeping sickness, diseases among the most prevalent in Africa.
Leave a Comment